Innovation in the Age of Disruption
To get some answers Centre for Digital Life Norway and The Life Science Cluster organized a webinar and expert panel discussion to have a conversation about innovation in the Age of Disruption, March 22nd this year.
Internationally recognized expert on innovation, entrepreneurship, and venture capital, Professor Jerome S. Engel from University of California at Berkeley, presented his thoughts on Innovation in the Age of Disruption with a focus on life sciences and healthcare.
Following up on Engel’s’ presentation, Professor Jeanette Hammer Andersen from University of Tromsø moderated an insightful discussion with Natsai Audrey Chieza, founder and CEO at Faber Futures, and Anita Patel Jusnes, patient Journey Chapter Lead at Roche.
Speakers & Contributors
Professor Jerome S. Engel is an internationally recognized expert on innovation, entrepreneurship, and venture capital, lecturing and advising business and government leaders around the world. His research and publications explore innovation ecosystems, technology commercialization, venture capital, and lean innovation management practices in established and emerging enterprises. After a successful business career, Professor Engel joined the faculty of the University of California at Berkeley in 1991, where he is currently Adjunct Professor Emeritus at the Haas School of Business. Professor Engel’s publications, including two books, Clusters of Innovation: Entrepreneurial engines of economic growth around the world [2014] and Clusters of Innovation in the Age of Disruption [2022], focus on the nature of innovation processes in entrepreneurial ventures, major corporations, and venture capital in regional ecosystems and global networks. Learn more on Engel's website.
Natsai Audrey Chieza is founder and CEO at Faber Futures. She is a leading thinker on the transformative role design can play in the equitable development of consumer biotechnology. With over ten years of experience co-developing multi-sector innovation strategies and shaping policy with global institutions, she leads a dynamic team that translates value and transforms systems across education, design, life science and manufacturing industries. Over a decade of experimentation, Chieza established novel design-driven processes and for bacteria textile colouration, which have been exhibited internationally. A TED speaker, Chieza is a member of the current session of the World Economic Forum's Global Futures Council on Synthetic Biology, contributing to the industry's roadmap for a world changed by COVID-19. Follow here: @faberfutures @natsaiaudrey
Anita Patel Jusnes has almost 25 years of experience in biotechnology. With a background in pharmacy, she has held senior commercial roles in the Norwegian and international pharmaceutical industry, including at Glaxo Smithkline, Pronova Biopharma, Novartis, and Genetic Analysis. She is currently Patient Journey Chapter Lead at Roche, which is a member of The Life Science Cluster. Anita is passionate about the healthcare industry and patient journeys: “It’s all about finding sustainable solutions.”
Professor Jeanette Hammer Andersen is head of Marbio and Professor in Marine Bioprospecting at the Norwegian College of Fishery Science, University of Tromsø – the Arctic University of Norway. Hammer Andersen is a member of the Centre for Digital Life Norway’s Expert Task Force. She leads Marbio in focusing on screening terrestrial and marine organisms and has successfully identified several novel bioactive compounds. She received her PhD in Microbiology, working with inhibition of Herpesvirus infections using natural proteins/peptides. At Marbio, her work has focused on establishing an automated assay platform for antioxidant, antibacterial, diabetes, immunomodulating and anticancer screening. She will serve as moderator for the webinar. @hammerjeanet
Hanne Mette D. Kristensen is CEO of The Life Science Cluster.
Hanne Mette D. Kristensen has a solid background both as entrepreneur and biotech-CEO; she also has broad experience from clusters, both as an active member, and as member of the Board of Directors of Oslo Cancer Cluster and Norway Health Tech. She has also worked on the incubator / investor side of the industry and has a broad international network.
Hanne Mette came to The Life Science Cluster from Innovation Norway where she was special advisor for life science / health in the greater Oslo region and Invest in Norway. Through the years in Innovation Norway she has worked with financing, companies and clusters, in addition to national and international branding of the industry for collaboration partners and investors. She has e.g. been responsible for a joint Nordic pavilion and collaboration at the BIO International Convention, international Global Growth- and business networks within health, and for the coordination of strategic positioning of Norwegian health industry that was launched in 2019.
She has a master in biochemistry from the University of Oslo, and a Master of Technology Management (MTM) from MIT/NHH/NTNU.
Co-hosted by
